Results 141 to 150 of about 216,511 (181)

Hypoxia‐Induced ADAM23 Drives Neuron–Tumor Crosstalk and Therapeutic Resistance in Hepatocellular Carcinoma

open access: yesMolecular Carcinogenesis, Volume 65, Issue 12, Page 1533-1543, December 2026.
ABSTRACT Hypoxia and nutrient deprivation are fundamental drivers of tumor aggressiveness and therapeutic resistance in hepatocellular carcinoma (HCC). While the involvement of neural components in the tumor microenvironment (TME) is increasingly recognized, the molecular transducers linking metabolic stress to neuron–tumor crosstalk remain elusive ...
Taehyun Park   +5 more
wiley   +1 more source

Network based approach identifies miR‐145‐3p as a central regulatory hub associated to the progression from localized to metastatic medullary thyroid carcinoma

open access: yesThe Journal of Pathology, Volume 270, Issue 4, Page 468-480, December 2026.
Abstract Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor originating from calcitonin producing C‐cells and accounts for 1–5% of thyroid cancers. Total thyroidectomy is curative in localized disease (N0), whereas lymph node metastases (N1) are associated with poorer prognosis.
Anna Citarella   +24 more
wiley   +1 more source

Key Players and Pathways of Mast Cell Activation in Urticaria. [PDF]

open access: yesJ Inflamm Res
Jahn C   +4 more
europepmc   +1 more source

Integrated transcriptomic and metabolite analysis reveals the role of AktADT8 in the biosynthesis of phenylalanine and its derivatives in Akebia trifoliata

open access: yesThe Plant Genome, Volume 19, Issue 4, December 2026.
Abstract Arogenate dehydratase (ADT) is a key enzyme in plant phenylalanine (Phe) biosynthesis, providing precursors for protein and phenolic compounds. Akebia trifoliata is valued as a medicinal, fruit, and ornamental plant because of its abundance of Phe and derivatives.
Jie Li   +10 more
wiley   +1 more source

Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

open access: yesImmunology, Volume 179, Issue 4, Page 565-578, December 2026.
PSTPIP2 acts as a key brake on myeloid inflammation by suppressing IL‐1β‐driven signalling, macrophage dysregulation and inflammation‐associated bone remodelling. Its emerging roles in CRMO/CMO, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid support its potential as a biomarker and therapeutic target.
Erdong Zhang   +9 more
wiley   +1 more source

Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma. [PDF]

open access: yesExp Hematol Oncol
Yamazaki S   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy